Ozempic 1 MG/dose (4 MG/3 ML) 3ML
Ended Awarded
- Contract number
- SPE2DB25FC9F9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $42,032
Award facts
- Contract value 100% obligated
- $42,031.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) injectable medication with a ceiling value of $42,031.89. This is a firm fixed price contract with no set-aside designation, meaning it was competitively awarded. The performance location is identified as Conshohocken, Pennsylvania, which is also the headquarters location of the prime contractor. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's DLA Troop Support Medical IDC functions as a comprehensive global pharmaceutical support vehicle enabling the supply of a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The current delivery order for Ozempic, a diabetes medication, reflects the company's extensive portfolio of brand-name pharmaceuticals supplied through competitive federal contracting. The contract is scheduled for completion by June 17, 2025, representing a short-duration delivery order typical of pharmaceutical procurement under the larger indefinite delivery vehicle.
Quick answers
Who was awarded contract SPE2DB25FC9F9?
SPE2DB25FC9F9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 16, 2025.
How much is contract SPE2DB25FC9F9 worth?
The government has obligated $42,032 on SPE2DB25FC9F9.
Is contract SPE2DB25FC9F9 an order under another contract?
Yes. SPE2DB25FC9F9 is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FC9F9 competed?
The extent of competition for SPE2DB25FC9F9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award